Albert Einstein College of Medicine

Adimab, LLC

Mapp Biopharmaceutical, Inc.

Biopharmaceutical, Inc.

Larry Zeitlin

Laura M Walker

Kartik Chandran

Anna Z Wec

Zachary A Bornholdt

Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.

Monoclonal antibodies and cocktails for treatment of Ebola infections

Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially, similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.

Described herein are compositions and methods for the prevention and treatment of ebolavirus infection certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.

Growing community of inventors

San Diego, CA, United States of America

Larry Zeitlin